These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 27039996

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Interstitial lung disease in a patient with antisynthetase syndrome and no myositis.
    Plastiras SC, Soliotis FC, Vlachoyiannopoulos P, Tzelepis GE.
    Clin Rheumatol; 2007 Jan; 26(1):108-11. PubMed ID: 16328094
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
    Krystufková O, Vallerskog T, Helmers SB, Mann H, Putová I, Belácek J, Malmström V, Trollmo C, Vencovsky J, Lundberg IE.
    Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
    [Abstract] [Full Text] [Related]

  • 27. Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome.
    Marie I, Josse S, Decaux O, Diot E, Landron C, Roblot P, Jouneau S, Hatron PY, Hachulla E, Vittecoq O, Menard JF, Jouen F, Dominique S.
    Eur J Intern Med; 2013 Jul; 24(5):474-9. PubMed ID: 23375620
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase.
    Hirakata M, Suwa A, Takada T, Sato S, Nagai S, Genth E, Song YW, Mimori T, Targoff IN.
    Arthritis Rheum; 2007 Apr; 56(4):1295-303. PubMed ID: 17393393
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [The anti-synthetase syndrome].
    Bergoin C, Bure M, Tavernier JY, Lamblin C, Maurage CA, Remy-Jardin M, Wallaert B.
    Rev Mal Respir; 2002 Jun; 19(3):371-4. PubMed ID: 12161705
    [Abstract] [Full Text] [Related]

  • 32. Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature.
    Labirua-Iturburu A, Selva-O'Callaghan A, Vincze M, Dankó K, Vencovsky J, Fisher B, Charles P, Dastmalchi M, Lundberg IE.
    Medicine (Baltimore); 2012 Jul; 91(4):206-211. PubMed ID: 22732951
    [Abstract] [Full Text] [Related]

  • 33. Interstitial lung disease and myositis-specific and associated autoantibodies: Clinical manifestations, survival and the performance of the new ATS/ERS criteria for interstitial pneumonia with autoimmune features (IPAF).
    Mejía M, Herrera-Bringas D, Pérez-Román DI, Rivero H, Mateos-Toledo H, Castorena-García P, Figueroa JE, Rojas-Serrano J.
    Respir Med; 2017 Feb; 123():79-86. PubMed ID: 28137500
    [Abstract] [Full Text] [Related]

  • 34. Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody.
    Marie I, Lahaxe L, Benveniste O, Delavigne K, Adoue D, Mouthon L, Hachulla E, Constans J, Tiev K, Diot E, Levesque H, Boyer O, Jouen F.
    Br J Dermatol; 2010 Feb 01; 162(2):337-44. PubMed ID: 19845665
    [Abstract] [Full Text] [Related]

  • 35. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F, Meyer A, Tohmé A, Charuel JL, Musset L, Allenbach Y, Benveniste O.
    JAMA Neurol; 2018 Dec 01; 75(12):1528-1537. PubMed ID: 30208379
    [Abstract] [Full Text] [Related]

  • 36. Clinical features and prognosis of patients with idiopathic inflammatory myopathies and anti-Jo-1 antibodies.
    Mielnik P, Wiesik-Szewczyk E, Olesinska M, Chwalinska-Sadowska H, Zabek J.
    Autoimmunity; 2006 May 01; 39(3):243-7. PubMed ID: 16769658
    [Abstract] [Full Text] [Related]

  • 37. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome.
    Lega JC, Fabien N, Reynaud Q, Durieu I, Durupt S, Dutertre M, Cordier JF, Cottin V.
    Autoimmun Rev; 2014 Sep 01; 13(9):883-91. PubMed ID: 24704867
    [Abstract] [Full Text] [Related]

  • 38. A 65-year-old Woman With Persistent Dyspnea, Arthritis, and Raynaud's Phenomenon.
    Chong WH, Saha BK, Beegle S.
    Am J Med Sci; 2021 Apr 01; 361(4):526-533. PubMed ID: 33386120
    [Abstract] [Full Text] [Related]

  • 39. Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group.
    Trallero-Araguás E, Grau-Junyent JM, Labirua-Iturburu A, García-Hernández FJ, Monteagudo-Jiménez M, Fraile-Rodriguez G, Les-Bujanda I, Rodriguez-Carballeira M, Sáez-Comet L, Selva-O'Callaghan A, IIM Study Group and Autoimmune Diseases Study Group (GEAS) of the Spanish Society of Internal Medicine (SEMI).
    Semin Arthritis Rheum; 2016 Oct 01; 46(2):225-231. PubMed ID: 27139168
    [Abstract] [Full Text] [Related]

  • 40. Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome.
    Marie I, Hatron PY, Cherin P, Hachulla E, Diot E, Vittecoq O, Menard JF, Jouen F, Dominique S.
    Arthritis Res Ther; 2013 Oct 08; 15(5):R149. PubMed ID: 24286268
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.